Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2008
09/04/2008WO2008104557A1 Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants
09/04/2008WO2008104279A1 Imidazo[1,2-a]azines and their use as pharmaceuticals
09/04/2008WO2008104278A1 Imidazo[1,2-a] pyridines and their use as pharmaceuticals
09/04/2008WO2008039941A3 Scgb3a2 as a growth factor and anti-apoptotic agent
09/04/2008US20080214682 Methods of treating pneumonic plague
09/04/2008US20080214676 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors
09/04/2008US20080214672 Treatment of Asthma with Aryl Sulfonamides
09/04/2008US20080214660 Compounds and Methods for the Inhibition of the Expression of VCAM-1
09/04/2008US20080214623 N-(2,2-Dimethylpropyl)-6-{3-fluoro-5-[(3-isoxazolylamino)carbonyl]-2-methylphenyl}-3-pyridinecarboxamide; inhibitors of p38 kinase
09/04/2008US20080214615 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
09/04/2008US20080214600 Quaternized Quinuclidine Esters
09/04/2008US20080214585 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007)
09/04/2008US20080214578 2R)-2-[(2-amino-5-{[(1S)-1-(2-fluorophenyl)ethyl]thio}[1,3]thiazolo[4,5-d]pyrimidin-7-yl)amino]pentan-1-ol; neurodegenerative disorders, demyelinating disease, cardio- and cerebrovascular atherosclerotic disorders, peripheral artery disease, rheumatoid arthritis, pulmonary diseases su COPD, asthma
09/04/2008US20080214575 Piperidine derivatives useful as ccr5 antagonists
09/04/2008US20080214536 4-((4aR,10bR)-8,9-Dimethoxy-1,2,3,4,4a,10b-hexahydro-phenanthridin-6-yl)-N-(2-methoxyethyl)-N-methyl-benzamide; phosphodiesterase 4 inhibitors; respiratory system disorders
09/04/2008US20080214478 Small Peptides And Methods For Inhibiting The Infiltration Of Eosinophils Into Airways
09/04/2008US20080214477 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy
09/04/2008US20080214476 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy
09/04/2008US20080214475 Small Peptides And Methods For Inhibiting The Mucous Release Into Airways
09/04/2008US20080214474 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
09/04/2008US20080214473 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; treatment and prevention of respiratory system disorders; antiinflammatory agents; immunotherapy
09/04/2008US20080214472 Small Peptides And Methods For Treatment Of Arthritis
09/04/2008US20080214440 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity
09/04/2008US20080213298 Herbal Therapy for the Treatment of Asthma
09/04/2008US20080213263 Methods and compositions for treatment of immune dysfunction disorders
09/04/2008US20080213248 Methods and Systems for Treating Asthma and Other Respiratory Diseases
09/04/2008US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome
09/04/2008US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders
09/04/2008US20080213177 Nanoparticles Comprising Rna Ligands
09/04/2008CA2679126A1 Macrocyclic compound
09/04/2008CA2678587A1 O-desulfated heparins treating acute exacerbations of chronic obstructive pulmonary disease
09/04/2008CA2678159A1 Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants
09/04/2008CA2678097A1 New use of nitrites and nitrates and compositions containing these
09/03/2008EP1964925A1 Process for production of optically active 4-hydroxy-1,2,3,4 -tetrahydroquinolines
09/03/2008EP1964854A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
09/03/2008EP1964849A2 Transfection complexes
09/03/2008EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application
09/03/2008EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application
09/03/2008EP1964841A1 Imidazo[1,2-a]azine and their use as pharmaceuticals
09/03/2008EP1964840A1 Imidazo[1,2-a]pyridines and their use as pharmaceuticals
09/03/2008EP1964561A1 Inhibitors of IMPDH enzyme
09/03/2008EP1963307A1 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[0xy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
09/03/2008EP1963259A2 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
09/03/2008EP1962960A1 Micronization method
09/03/2008EP1962869A1 Treatment of respiratory diseases
09/03/2008EP1962848A2 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases
09/03/2008EP1701933B1 Novel compounds
09/03/2008EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/03/2008CN101258152A Pyridopyrimidine derivatives as PDE4 inhibitors for the treatment of inflammatory and immune diseases
09/03/2008CN101257913A Marrubiin and composition for reducing snoring, package and method
09/03/2008CN101257904A Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
09/03/2008CN101255439A Bird infectious bronchitis virus N-gene and bird IL-2 gene co-expressing DNA bacterin pIRES-N/IL2
09/03/2008CN101255199A Method for extracting Siberian solomonseal rhizome polysaccharide from siberian solomonseal rhizome
09/03/2008CN101255170A 2,3-dihydroimidazo[2,1-b]oxazole compound
09/03/2008CN101255162A Adenosine receptor antagonists and methods of making and using the same
09/03/2008CN101254305A Composite nasal cavity preparations for curing allergic rhinitis
09/03/2008CN101254296A Pharmaceutical combination with relieving cough, curing asthma and throat-moistening resolve phlegm effect and method of preparing the same
09/03/2008CN101254273A Chinese medicine composing prescription for curing chronic pharyngitis
09/03/2008CN101254268A Chinese medicine for curing coryza
09/03/2008CN101254263A Compound Japanese polygala oral liquid and method of preparing the same
09/03/2008CN101254258A Chuanwang anti-inflammation dispersible tablet and method of preparing the same
09/03/2008CN101254255A Traditional Chinese medicine preparation for curing cold
09/03/2008CN101254252A Nasosinusitis health-care composition
09/03/2008CN101254249A Chinese and Western compound preparations for curing cough and abundant sputum symptoms and method of preparing the same
09/03/2008CN101254237A Preparation of pharmaceutical combination enteric soft capsules containing eucalyptol, limonene and a-pinene
09/03/2008CN101254233A Gene therapy for radical curing SARS respiratory disease
09/03/2008CN101254231A Preparation for curing perennial allergic rhinitis external-use traditional Chinese medicine preparation
09/03/2008CN101254229A Medicament preventing and treating viral infection of upper respiratory tract and method of preparing the same
09/03/2008CN101254172A Guacetisal dry-mixing suspending agents and method of preparing the same
09/03/2008CN100415895C Non-splicing variant of gp 350/220
09/03/2008CN100415747C Phosphodiesterase 4 inhibitors
09/03/2008CN100415743C Derivatives of pyrimido [6.1-a] isoquinolin-4-one
09/03/2008CN100415724C Pyrimidine derivatives
09/03/2008CN100415723C Benzimidazole derivative
09/03/2008CN100415719C 2,5-disubstituted 3-mercaptopentanoic acid
09/03/2008CN100415718C CASPASE inhibitors and use thereof
09/03/2008CN100415269C Cow-bezoar snake bile Sichuan fritillary bulb dispersive tablet and its preparation method
09/03/2008CN100415255C Composition of Chinese traditional medicine, and preparation method thereof
09/03/2008CN100415248C Masa Medicata Fermentate health-care preparation, and its preparation method
09/03/2008CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection
09/03/2008CN100415223C Controlled releasing oral medicine composition
09/02/2008US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
09/02/2008US7420050 TGF-β-specific covalently closed antisense molecule
09/02/2008US7419999 Gamma lactams as prostaglandin agonists and use thereof
09/02/2008US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
09/02/2008US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
09/02/2008US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation
09/02/2008US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant
09/02/2008US7419664 Expression or activity of soluble CLCA1(chloride channel A1) is up-regulated, by administering inhibitors of soluble CLCA1
09/02/2008CA2466728C Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1
09/02/2008CA2440468C Pregabalin lactose conjugates
09/02/2008CA2388140C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
09/02/2008CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent
08/2008
08/28/2008WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
08/28/2008WO2008103426A1 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
08/28/2008WO2008103126A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
08/28/2008WO2008103125A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
08/28/2008WO2008102151A1 Medical uses of glucans
08/28/2008WO2008102128A2 Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
08/28/2008WO2008101591A1 Novel methods